Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
10:41am, Wednesday, 10'th Apr 2024
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius Medical (FMS) to Unveil Training on Augmented Reality
12:11pm, Monday, 25'th Mar 2024
Fresenius Medical (FMS) is launching digital learning elements with hands-on training for Kidney Replacement Therapy leveraging Augmented Reality.
Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care
08:00am, Friday, 22'nd Mar 2024
Fresenius Medical Care delivers on commitments during a year of fundamental transformation Progress towards sustainability goals in key areas: patient satisfaction, diversity in management, climate ta
Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device
08:00am, Tuesday, 19'th Mar 2024
For the first time, Fresenius Medical Care develops and utilizes "Augmented Reality" (AR) to train medical staff in Intensive Care Units (ICUs) The new training application for ICU staff combines digi
Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources
10:00am, Wednesday, 13'th Mar 2024
Effective June 1, the Legal, Compliance, and Human Resources functions will be combined in a new Management Board role Jörg Häring contributes his extensive expertise from the energy, industry, and
Fresenius Medical (FMS) Divests Assets to Optimize Portfolio
10:46am, Monday, 11'th Mar 2024
Fresenius Medical's (FMS) latest asset divestments reflect a milestone in its portfolio optimization program and are likely to improve profitability.
Divestment of assets includes four separate country transactions to DaVita Inc. for USD 300 million Transactions further reduce the Company`s clinic footprint in Latin America, following the exit from
Fresenius Medical (FMS) Q4 Earnings Beat, Operating Margin Up
08:56am, Wednesday, 21'st Feb 2024
Fresenius Medical's (FMS) fourth-quarter revenues suffer due to unfavorable currency movement. However, the company?
Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript
12:03pm, Tuesday, 20'th Feb 2024
Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript
Fresenius Medical Care delivers on commitments in a year of fundamental transformation
07:30am, Tuesday, 20'th Feb 2024
Revenue growth of 5% in 2023 driven by favorable business development Operating income1 growth of 15% exceeding top end of outlook range, due to business growth, FME25 savings ahead of plan and contri
Fresenius Medical (FMS) Gets FDA Nod for New Hemodialysis System
11:51am, Friday, 09'th Feb 2024
Fresenius Medical (FMS) receives an FDA nod for its new 5008X Hemodialysis System that aims to provide better dialysis therapy for kidney patients in the United States.
Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company's 5008X Hemodialysis System. This will enable Fresenius Medical Care to offer the industry
Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board
08:57am, Monday, 05'th Feb 2024
BAD HOMBURG, Germany , Feb. 5, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has nominated six employee
Fresenius Medical (FMS) Divests Businesses to Optimize Portfolio
11:16am, Tuesday, 09'th Jan 2024
Fresenius Medical (FMS) streamlines for success with three key divestments in 2023. These divestments are likely to impact operating income by EUR 500 million in the fourth quarter.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
02:16pm, Wednesday, 20'th Dec 2023
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
